文献速递妇科生殖医学

青少年和年轻成人子宫内膜异位症相关的血浆代谢物

Plasma metabolites associated with endometriosis in adolescents and young adults.
PubMed 文献 · Hum Reprod · 2025-01-01

横断面分析纳入190例经腹腔镜确诊的子宫内膜异位症病例和120例对照,采用液相色谱-串联质谱检测430种已知血浆代谢物。病例组脂肪酸酰基和神经酰胺升高、类固醇及其衍生物降低;术后55种相关代谢物显著变化,神经酰胺术后未变且仍高于对照。

要点

  • 病例组血浆脂肪酸酰基(FDR=2.3e-4)和神经酰胺(FDR=6.0e-3)升高,类固醇及其衍生物降低(FDR=1.3e-4)。
  • 病例组促炎反应相关代谢物(如二十碳三烯酸β=0.61,95%CI=0.37,0.86)和氧化应激相关代谢物(如黄嘌呤β=0.64,95%CI=0.39,0.88)升高。
  • 术后55种子宫内膜异位症相关代谢物显著变化,类固醇及其衍生物升高(FDR=8.1e-4),脂肪酸酰基降低(FDR=1.2e-4),神经酰胺未变且仍高于对照(FDR=3.9e-3)。

核心结论

  • 青少年和年轻成人子宫内膜异位症患者血浆代谢组学谱存在失调,病例组较对照全身性脂肪酸酰基和神经酰胺升高。
  • 研究结果提示子宫内膜异位症相关手术对年轻患者全身代谢失调有正面影响,但并非全部代谢物均改善。
  • 这些结果需进一步研究治疗后持续存在的全身性改变是否及如何导致子宫内膜异位症患者长期慢性疾病风险。

研究设计与样本

  • 横断面分析,纳入190例经腹腔镜确诊的子宫内膜异位症病例和120例对照,对照为无子宫内膜异位症诊断的女性,来自与病例相同的诊所或从一般人群招募。
  • 参与者来自「女性健康研究:从青春期到成年」(The Women's Health Study: From Adolescence to Adulthood)队列,入组时间为2012年至2018年。
  • 病例中81例有手术前后采集的血样;采用液相色谱-串联质谱检测入组时采集血液中的430种已知血浆代谢物。
  • 采用线性回归校正采血年龄、BMI、激素使用和采血时禁食状态;使用代谢物集富集分析(MSEA)识别代谢物类别;采用有效检验数(NEF)和错误发现率(FDR)进行多重检验校正。

主要发现

  • 子宫内膜异位症病例中位年龄17岁,对照中位年龄22岁;大多数病例为rASRM I期或II期(>95%)。
  • 共鉴定出63种与子宫内膜异位症相关的血浆代谢物(NEF<0.05)。
  • 病例组促炎反应相关代谢物较高,如二十碳三烯酸(β=0.61,95%CI=0.37,0.86);氧化应激反应相关代谢物较高,如黄嘌呤(β=0.64,95%CI=0.39,0.88);凋亡相关代谢物下调,如甘胆酸(β=-0.80,95%CI=-1.04,-0.56)。
  • MSEA显示病例组较对照脂肪酸酰基升高(FDR=2.3e-4)、神经酰胺升高(FDR=6.0e-3)、类固醇及其衍生物降低(FDR=1.3e-4)。
  • 在81例有手术前后血样的病例中,55种子宫内膜异位症相关代谢物手术前后显著变化;MSEA显示术后类固醇及其衍生物显著升高(FDR=8.1e-4),脂肪酸酰基显著降低(FDR=1.2e-4);神经酰胺手术前后未变化,且术后血中仍高于对照(FDR=3.9e-3)。

局限性

  • 研究人群主要由自我报告的非西班牙裔白人个体和仅有浅表腹膜病灶的子宫内膜异位症病例组成,普遍性可能有限。
  • 尽管研究人群为青少年和年轻成人子宫内膜异位症患者且样本量较大,但样本量仍有限,无法进行详细的血浆代谢组学分层分析,尤其是按术后盆腔疼痛结局分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the plasma metabolomics profiles associated with endometriosis in adolescents and young adults? SUMMARY ANSWER: Our findings show dysregulation of plasma metabolomic profiles in adolescents and young adults with endometriosis, revealing systemic elevation of fatty acyls and ceramides in endometriosis cases compared to controls. WHAT IS KNOWN ALREADY: Endometriosis is a gynecologic disease often presenting with severe pelvic pain impacting around 200 million reproductive-aged women worldwide. However, little is known about the pathophysiology and molecular features of endometriosis diagnosed during adolescence and young adulthood. STUDY DESIGN, SIZE, DURATION: We conducted a cross-sectional analysis including 190 laparoscopically confirmed endometriosis cases and 120 controls who participated in The Women's Health Study: From Adolescence to Adulthood, which enrolled participants from 2012 to 2018. Control participants were females without a diagnosis of endometriosis enrolled from the same clinics as the cases or recruited from the general population. Among the cases, 81 had blood samples collected before and after surgery. PARTICIPANTS/MATERIALS, SETTING, METHODS: Plasma metabolites were measured in blood collected at enrollment using liquid chromatography-tandem mass spectrometry, and a total of 430 known metabolites were evaluated in our analysis. We used linear regression adjusting for age at blood draw, BMI, hormone use, and fasting status at blood draw. Metabolite set enrichment analysis (MSEA) was used to identify metabolite classes. Number of effective tests (NEF) and false discovery rate (FDR) were used for multiple testing correction. MAIN RESULTS AND THE ROLE OF CHANCE: The median age was 17 years for endometriosis cases and 22 years for controls. The majority of endometriosis cases had rASRM stage I or II (>95%). We identified 63 plasma metabolites associated with endometriosis (NEF < 0.05). Endometriosis cases had higher levels of plasma metabolites associated with proinflammatory response [e.g. eicosatrienoic acid (β = 0.61, 95% CI = 0.37, 0.86)], increased oxidative stress response [e.g. xanthine (β = 0.64, 95% CI = 0.39, 0.88)], and downregulation of metabolites related to apoptosis [glycocholic acid (β = -0.80, 95% CI = -1.04, -0.56)]. MSEA revealed increased fatty acyls (FDR = 2.3e-4) and ceramides (FDR = 6.0e-3) and decreased steroids and steroid derivatives (FDR = 1.3e-4) in endometriosis cases compared to controls. When we examined the changes in plasma metabolite profiles before and after surgery among endometriosis cases, 55 endometriosis-associated metabolites significantly changed from before to after surgery. MSEA revealed steroids and steroid derivatives (FDR = 8.1e-4) significantly increased after surgery, while fatty acyls (FDR = 1.2e-4) significantly decreased after surgery. Ceramides did not change from pre- to post-surgery and were elevated in post-surgical blood compared to controls (FDR = 3.9e-3). LIMITATIONS, REASONS FOR CAUTION: Our study population mainly consists of self-reported non-Hispanic, white individuals and endometriosis cases with superficial peritoneal lesions only, so the generalizability may be limited. Furthermore, despite our large study population of adolescents and young adults with endometriosis, sample size was limited to conduct detailed stratified analyses of plasma metabolomic profiles, especially by post-surgical pelvic pain outcomes. WIDER IMPLICATIONS OF THE FINDINGS: Our study includes the utilization of state-of-the-art metabolomics technology with high reproducibility to comprehensively investigate the metabolites that were associated with endometriosis diagnosed in adolescents and young adults. Our results suggest a positive impact of endometriosis-related surgery for some, but not all, on systemic metabolic dysregulation in young patients with endometriosis. These results warrant further investigation on whether and how persistent systemic changes despite treatment may lead to long-term chronic disease risk among those diagnosed with endometriosis. STUDY FUNDING/COMPETING INTEREST(S): Financial support for establishment of and data collection within the A2A cohort was provided by the J. Willard and Alice S. Marriott Foundation, and support for assay costs was in part provided by the Peery family. This project was funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development R21HD107266. S.A.M., A.L.S., and K.L.T. were supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD094842. S.A.M. received grant funding from AbbVie, National Institutes of Health, Department of Defense, and Marriott Family Foundation; received honoraria from WERF, Huilun Shanghai, and University of Kansas Medical Center; travel support from SRI, ESHRE, FWGBD, University of Michigan, MIT, ASRM, LIDEA Registry, Taiwan Endometriosis Society, SEUD, Japan Endometriosis Society, NASEM, Endometriosis Foundation of America, Gedeon Richter Symposium at ESHRE; Board member receiving financial remuneration from AbbVie, Roche, LIDEA Registry, Editor of Frontiers in Reproductive Health, Roundtable participation for Abbott; Board member without financial remuneration from NextGen Jane and Statistical Advisory Board member of Human Reproduction; leadership role in Society for Women's Health Research, World Endometriosis Society, World Endometriosis Research Foundation, ASRM, ESHRE. N.S. and K.L.T. receive grant funding from Aspira Women's Health unrelated to this project. The remaining authors have no disclosures relevant to this manuscript. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lin N, Zeleznik OA, Vitonis AF, et al. Plasma metabolites associated with endometriosis in adolescents and young adults. Hum Reprod. 2025. PMID: 40107296. doi:10.1093/humrep/deaf040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。